Skip to main content
OpenTrials

Clinical trial condition

Hormone Receptor Positive Breast Carcinoma

Explore clinical trials studying Hormone Receptor Positive Breast Carcinoma. Study availability and eligibility vary by location and protocol.

21 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Hormone Receptor Positive Breast Carcinoma trial results

Recruiting

Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype

NCT06486883

Conditions
Advanced Breast Cancer, Advanced Breast Carcinoma, Hormone Receptor Positive Breast Carcinoma
Locations
  • Kepler Universitäts Klinikum Linz, Austria
  • Medical University of Vienna Vienna, Austria
  • Algemeen Ziekenhuis Klina Brasschaat, Belgium
  • Ghent University Hospital Ghent, Belgium
View all 79 locations
View Trial Details
Recruiting

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

NCT06120283

Conditions
Advanced Breast Cancer, Advanced Solid Tumor, Breast Diseases, +20 more
Locations
  • Sarah Cannon Research Institute (Scri) At Health One Denver, Colorado, United States
  • Florida Cancer Specialists and Research Institute Lake Mary, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 63 locations
View Trial Details
Recruiting

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

NCT04305834

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • City of Hope at Long Beach Elm Long Beach, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View Trial Details
Recruiting

A Study of Revaree Plus in People With Breast Cancer

NCT07042581

Conditions
Breast Cancer, Breast Carcinoma In Situ, Breast Diseases, +19 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center Suffolk-Commack (Consent Only) Commack, New York, United States
View Trial Details
Recruiting

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

NCT04553770

Conditions
Breast Diseases, Breast Neoplasms, Early-Stage Breast Cancer, +10 more
Locations
  • St. Joseph Heritage Healthcare Fullerton, California, United States
  • Cancer Blood and Specialty Clinic Los Alamitos, California, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Torrance Memorial Physician Network / Cancer Care Torrance, California, United States
View Trial Details
Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT06805812

Conditions
Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more
Locations
  • Centro di Riferimento Oncologico IRCCS Aviano, Italy
  • Azienda Socio Sanitaria Territoriale degli Spedali Civili Brescia, Italy
  • Humanitas Istituto Clinico Catanese Catania, Italy
  • ASST Lariana - Ospedale Sant'Anna Como, Italy
View all 24 locations
View Trial Details

Related conditions